136 related articles for article (PubMed ID: 18780974)
21. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
[TBL] [Abstract][Full Text] [Related]
22. The n-terminal 5-MER peptide analogue P165 of amyloid precursor protein exerts protective effects on SH-SY5Y cells and rat hippocampus neuronal synapses.
Wang P; Jiang S; Cui Y; Yue Z; Su C; Sun J; Sheng S; Tian J
Neuroscience; 2011 Jan; 173():169-78. PubMed ID: 21055450
[TBL] [Abstract][Full Text] [Related]
23. Pin1 Modulates the Synaptic Content of NMDA Receptors via Prolyl-Isomerization of PSD-95.
Antonelli R; De Filippo R; Middei S; Stancheva S; Pastore B; Ammassari-Teule M; Barberis A; Cherubini E; Zacchi P
J Neurosci; 2016 May; 36(20):5437-47. PubMed ID: 27194325
[TBL] [Abstract][Full Text] [Related]
24. Region-specific expression of tau, amyloid-β protein precursor, and synaptic proteins at physiological condition or under endoplasmic reticulum stress in rats.
Lin L; Yang SS; Chu J; Wang L; Ning LN; Zhang T; Jiang Q; Tian Q; Wang JZ
J Alzheimers Dis; 2014; 41(4):1149-63. PubMed ID: 24787918
[TBL] [Abstract][Full Text] [Related]
25. Molecular evidence for decreased synaptic efficacy in the postmortem olfactory bulb of individuals with schizophrenia.
Egbujo CN; Sinclair D; Borgmann-Winter KE; Arnold SE; Turetsky BI; Hahn CG
Schizophr Res; 2015 Oct; 168(1-2):554-62. PubMed ID: 26260078
[TBL] [Abstract][Full Text] [Related]
26. Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.
Kristiansen LV; Beneyto M; Haroutunian V; Meador-Woodruff JH
Mol Psychiatry; 2006 Aug; 11(8):737-47, 705. PubMed ID: 16702973
[TBL] [Abstract][Full Text] [Related]
27. Comparing development of synaptic proteins in rat visual, somatosensory, and frontal cortex.
Pinto JG; Jones DG; Murphy KM
Front Neural Circuits; 2013; 7():97. PubMed ID: 23754984
[TBL] [Abstract][Full Text] [Related]
28. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
29. PSD-95 regulates synaptic transmission and plasticity in rat cerebral cortex.
Béïque JC; Andrade R
J Physiol; 2003 Feb; 546(Pt 3):859-67. PubMed ID: 12563010
[TBL] [Abstract][Full Text] [Related]
30. Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging.
Wang DS; Lipton RB; Katz MJ; Davies P; Buschke H; Kuslansky G; Verghese J; Younkin SG; Eckman C; Dickson DW
J Neuropathol Exp Neurol; 2005 May; 64(5):378-85. PubMed ID: 15892294
[TBL] [Abstract][Full Text] [Related]
31. Synaptic protein levels altered in vascular dementia.
Sinclair LI; Tayler HM; Love S
Neuropathol Appl Neurobiol; 2015 Jun; 41(4):533-43. PubMed ID: 25559750
[TBL] [Abstract][Full Text] [Related]
32. Premorbid effects of APOE on synaptic proteins in human temporal neocortex.
Love S; Siew LK; Dawbarn D; Wilcock GK; Ben-Shlomo Y; Allen SJ
Neurobiol Aging; 2006 Jun; 27(6):797-803. PubMed ID: 15979210
[TBL] [Abstract][Full Text] [Related]
33. Postsynaptic density 95 controls AMPA receptor incorporation during long-term potentiation and experience-driven synaptic plasticity.
Ehrlich I; Malinow R
J Neurosci; 2004 Jan; 24(4):916-27. PubMed ID: 14749436
[TBL] [Abstract][Full Text] [Related]
34. Immunoelectron microscopic study of synaptic pathology in Alzheimer's disease.
Masliah E; Hansen L; Albright T; Mallory M; Terry RD
Acta Neuropathol; 1991; 81(4):428-33. PubMed ID: 1903014
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease.
Masliah E; Mallory M; Alford M; DeTeresa R; Hansen LA; McKeel DW; Morris JC
Neurology; 2001 Jan; 56(1):127-9. PubMed ID: 11148253
[TBL] [Abstract][Full Text] [Related]
36. Rapid redistribution of synaptic PSD-95 in the neocortex in vivo.
Gray NW; Weimer RM; Bureau I; Svoboda K
PLoS Biol; 2006 Nov; 4(11):e370. PubMed ID: 17090216
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
[TBL] [Abstract][Full Text] [Related]
38. Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats.
Wang X; Xing A; Xu C; Cai Q; Liu H; Li L
J Alzheimers Dis; 2010; 21(3):813-22. PubMed ID: 20634588
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease.
Masliah E; Terry RD; DeTeresa RM; Hansen LA
Neurosci Lett; 1989 Aug; 103(2):234-9. PubMed ID: 2505201
[TBL] [Abstract][Full Text] [Related]
40. Accumulation of a repulsive axonal guidance molecule RGMa in amyloid plaques: a possible hallmark of regenerative failure in Alzheimer's disease brains.
Satoh J; Tabunoki H; Ishida T; Saito Y; Arima K
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):109-20. PubMed ID: 22582881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
